Sciwind secures China’s NMPA approval for Ecnoglutide injection
Ecnoglutide is distinguished by its selective activation of the cAMP signalling pathway, reducing β-arrestin recruitment.
Drug Development
BMS gains FDA approval for Sotyktu in psoriatic arthritis treatment
J&J announces Tecvayli-Darzalex combo approval from FDA for multiple myeloma
Liberate Bio gains licences for myeloid-specific CAR design patents
CordenPharma leases space at Flatiron Park for peptides development
Affinia receives FDA fast track designation for AFTX-201
Aspire Biopharma and Microsize collaborate for alprazolam powder formulation
Esperion to acquire Corstasis for cardiovascular franchise expansion
